Key result
Extracellular ATP released from activated platelets during pulmonary embolism is proposed to play a mechanistic role in triggering vagal reflexes that lead to bradycardia and syncope.
ATP released from activated platelets during pulmonary embolism may trigger vagal reflexes causing bradycardia and syncope, highlighting P2X3R antagonists as potential future therapies.
Answers are grounded in this paper and cite their sources.
Offers no immediate clinical implications for PE; leaves open P2X3R antagonist investigation.
Adenosine 5'-triphiosphate (ATP) is released from cells under physiologic and pathophysiologic conditions. Extracellular ATP acts as an autocrine and paracrine agent affecting various cell types by activating cell surface P2 receptors (P2R), which include trans-cell membrane cationic channels, P2XR, and G protein coupled receptors, P2YR. We have previously shown that ATP stimulates vagal afferent nerve terminals in the lungs by activating P2X2/3R. This action could lead to bronchoconstriction, cough and the local release of pro-inflammatory neuropeptides. In addition, ATP markedly enhances the IgE-dependent histamine release from human lung mast cells. Thus, we have proposed for the first time that extracellular ATP plays a mechanistic role in pulmonary pathophysiology in general and chronic obstructive pulmonary disease (COPD), and acute bronchoconstriction in asthma in particular. The present review examines whether ATP could also play a role in bradycardia and syncope in a subset of patients with pulmonary embolism.
No takes yet. Share an insight, caveat, or question.
Pelleg et al. (2018) conducted a review in Pulmonary embolism with bradycardia and syncope. Extracellular ATP was evaluated. Extracellular ATP released from activated platelets during pulmonary embolism is proposed to play a mechanistic role in triggering vagal reflexes that lead to bradycardia and syncope.
Synapse has enriched 10 related papers. Consider them for comparative context: